Thirty-four edematous cardiac patients who were being treated with cation exchange resin were studied for its long term effectiveness and for clinical and chemical complications. In 23 of 27 patients the resin was effective in terms of mobilizing edema fluid previously refractory to other forms of treatment, of partial or complete substitution for mercurial diuretics, and of permitting a slight increase in the salt content of the diet. Gastrointestinal intolerance was the chief clinical complication but prevented therapy in only five patients. Chemical complications of sodium depletion, potassium depletion or excess, and severe chloride acidosis were not seen.
By W. C. KLINGENSMITH Thirty-four edematous cardiac patients who were being treated with cation exchange resin were studied for its long term effectiveness and for clinical and chemical complications. In 23 of 27 patients the resin was effective in terms of mobilizing edema fluid previously refractory to other forms of treatment, of partial or complete substitution for mercurial diuretics, and of permitting a slight increase in the salt content of the diet. Gastrointestinal intolerance was the chief clinical complication but prevented therapy in only five patients. Chemical complications of sodium depletion, potassium depletion or excess, and severe chloride acidosis were not seen.
' N THE preceding paper' data were presented concerning some of the electrolyte exchanges which result from the use of cation exchange resin in edematous cardiac patients. It was shown that resin will increase the fecal excretion of sodium and potassium, and that in certain patients, previously refractory to treatment with mercurial diuretics, the addition of resin therapy appeared to cause the elimination of their edema. This loss of edema resulted from increased urinary as well as fecal excretion of sodium. These studies, however, gave no information concerning the clinical effectiveness of the administration of resin to such patients over a prolonged period of time, or of the possible complications of such therapy during its long-term use. It is the purpose of this paper to supply such information.
EXPERIMENTAL MATERIAL Observations were made on a total of 34 patients with peripheral edema due to congestive heart failure. The etiologies of the heart disease in these patients were as follows: chronic rheumatic disease, 15; hypertension, 10; arteriosclerosis, 7; and syphilis, 2. In 27 of these patients resin therapy was continued long enough to evaluate its long-term effectiveness, the maximum period of treatment being 62 weeks and the average period being 26.4 weeks. The remaining seven patients of the total series are included in order to give a fair picture of patient tolerance to the preparation.
The 27 patients in whom long-term therapy with resin was evaluated are placed in three classifications for purposes of analysis. Class I is made up of 16 patients in whom congestive heart failure persisted despite intensive treatment by standard methods. These methods included digitalization, sodium deprivation (below 500 mg. daily in most cases), frequent administration of mercurial diuretics, and restricted activity including a period of bed rest in the hospital during the initial period of study. Class II consisted of five patients who had been maintained in an edema-free state en an 800 to 2000 mg. sodium diet by the administration of digitalis and mercurial diuretics. Class III included six edematous patients who were en digitalis but who were unable to take mercurial diuretics due to sensitivity to the drug. Besides the 27 patients included in these three classes, seven patients are tabulated as class IV who were unable to tolerate the resin over a prolonged period or who were not followed closely enough to permit adequate evaluation. 844 a in six patients and were sufficiently severe to necessitate discontinuation of therapy permanently in two, and temporarily in three patients. Anorexia or nausea without vomiting were observed in nine patients and in two of these were sufficiently severe to stop the therapy. Two patients vomited the resin when initially administered and so could not be treated.
Muscle cramps occurred occasionally in two patients; one of these had had more severe cramps following mercurial diuretics. incidence of such complications are presented as follows. Sodium depletion with concomitant peripheral vascular collapse and renal failure was looked for as a possible result of overtreatment with resin. Since this condition in cardiac patients, commonly called the "low salt syndrome," is usually accompanied by hyponatremia,3 4 the cardinal chemical index was the serum concentration of sodium. In figure 2 (fig. 3) . Following discontinuation of his resin therapy, the acidosis responded to treatment with sodium bicarbonate but the azotemia progressed until death two weeks later. In three other patients, one of whom had a normal control value, the blood urea nitrogen increased slightly. In six of eight patients with a mild degree of azotemia before resin, the azotemia decreased during therapy. Thus, despite the report of the production of urinary casts by resin,7 renal failure was not a direct complication of resin therapy in our series.
Calcium depletion was a possible complication since ammonium cycle resin is known to take up this divalent cation preferentially in vitro. Serum concentrations of calcium were determined 30 times in 12 patients during therapy. No values were found below 9.0 mg. per 100 ml. Although the maintenance of a normal serum level does not rule out a slow depletion of the calcium stores of the body, it does suggest that such did not occur to a serious extent. There was no evidence of tetany. X-ray studies for decalcification were not made.
DISCUSSION
The results obtained in this study indicate clearly that the administration of cation exchange resin is a useful adjunct in the treatment of patients with congestive heart failure. It appears to be helpful in the control of such edema over prolonged periods of time as well as in the treatment of edema which has become refractory to other forms of therapy.' The term "adjunct" is used advisedly, since the use of resin did not remove the necessity of employing other accepted methods of treatment. Digitalis preparations were administered to all of the patients in the usual doses, and physical activity was restricted. The resin, therefore, modified the previous therapeutic regimen in two ways: (1) the partial or complete elimination of mercurial diuretics, and (2) an increase in the salt content of the diet.
Mercurial diuretics have been such an extremely useful tool in the treatment of cardiac edema that they are unlikely to be supplanted by exchange resins. However, mercurial therapy has its limitations. Some patients are sensitive to these drugs. Some patients become refractory to the diuretic action of mercurials, and in some a "low salt syndrome," characterized by peripheral vascular collapse and progressive renal failure, may ensue.4 For these reasons cation exchange resin may be a useful adjunct in potentiating the action of mercury in refractory patients,1 in reducing the number of doses, or in eliminating entirely the necessity for the drug.
Resin therapy in edematous patients was originally introduced with the thought that it would obviate the necessity for an unpalatable salt-free diet. The evidence of other investigators, as well as of our own, supports this concept within certain limits. Resin appears to take up primarily exogenous or dietary sodium, but the degree to which it does so is limited. Thus, in the group of patients reported here it was usually possible during resin therapy to change from a "salt-free" diet (less than 500 mg. of sodium) to a "low-salt" diet (800 to 1600 mg. of sodium). This latter diet contains 35 to 70 mEq. of sodium, an amount which somewhat exceeds the daily fecal sodium exere-tion observed in patients on ammonium plus potassium resin (Resodec) but which lies within the range of 40 to 90 mEq. of sodium in stools excreted by the usual route by patients receiving ammonium cycle resin.' When the dietary intake of sodium was increased above this range (2000 to 2400 mg. of sodium or 85 to 100 mEq. of sodium) edema fluid began to reaccumulate. Resin, therefore, does not give a carte blanche for adding salt to the diet. However, the difficulty in preparation of a 500 mg. sodium diet as compared to an 800 to 1600 mg. sodium diet is such that there is a very real advantage in the use of resin on this score.
Against these advantages certain disadvantages must be weighed. One of these is the present high cost of the drug. However, this disadvantage soon may be minimized as a result of improved methods of production and commercial competition. More serious is the problem of gastrointestinal intolerance, the incidence of which was high in this group of patients. Anorexia and nausea may be controlled in the majority of instances by a trial and error attempt at finding the most suitable liquid in which to suspend the resin for administration. In addition, reactions of this type frequently were minimized by permitting the patient to take the resin suspension in small sips during meals, and by guarding against settling of the resin towards the bottom of the suspension.
Constipation was a common complication in the series but was usually controlled by the use of mineral oil and a mild laxative. Abdominal cramps and diarrhea were more difficult to treat and sometimes necessitated a period of rest from the resin administration. These difficulties encountered in resin therapy indicate the need for improvement of the agent along lines of increased palatability and increased effectiveness in cation exchange permitting the use of smaller doses of resin. Nevertheless, most of our patients found that the advantages of the resin outweighed the difficulties and were willing to continue the therapy.
The data reported on this series of patients are reassuring in regard to the potential biochemical hazards of the use of cation exchange resins over a prolonged period of time. The occurrence of sodium depletion with peripheral vascular collapse and renal failure has been reported to occur following the use of such resins.8'9 In our series these complications were not observed; this inclines us to the belief that, properly guarded against, such complications are not a common danger. Potassium depletion was reported early in the experimental use of ammonium cycle resin'0 and was the reason for adding potassium cycle resin to the ammonium form for ordinary therapeutic use. While carboxylic resin combined in these two cycles is less effective in removing sodium than the ammonium cycle resin alone,' it does appear not only to have been clinically effective in controlling edema but also to have prevented the development of a serious degree of potassium depletion during prolonged use. On the other hand, another complication was anticipated from the addition of the potassium cycle resin to the regimen, namely, potassium retention and intoxication. Such intoxication is usually the result of renal insufficiency" and might be anticipated in a group of edematous cardiacs whose renal function is generally less than optimum. Nevertheless, in our group of patients this complication was not encountered, its absence probably being due to the usual avoidance of patients with any marked degree of renal failure.
The production of a severe degree of chloride acidosis has been considered to be one of the principal hazards of the use of cation exchange resins,2' 12, 13 and has been the reason for the combination of an anion exchanger with the cation exchange resin.'4 Such a complication does occur readily in patients with a severe degree of renal disease," but did not occur in our group of edematous cardiac patients. In wisely selected patients, therefore, fear of such a complication should not deter the physician from the use of ammonium or hydrogen plus potassium cycle resins. The employment of a combination of anion and cation exchange resins may well have a place in treating edematous patients with advanced renal failure, but such combinations may be less effective in treating edematous cardiac patients without renal failure. The presence of a mild acidosis has long been known to predispose toward a diuresis, and the data in the preceding paper suggest that it may be one factor in the potentiation by resin of the renal effect of mercurial diuretics. ' Evidence of calcium depletion was not found in this series although the resin has been shown to have a preferential affinity for divalent cations in vitro. In vivo balance studies have indicated that large amounts of calcium are not lost with ammonium and hydrogen cycle resins,'6 presumably because of the low concentration of dissolved calcium in comparison with that of sodium in gastrointestinal fluids. The data on this point in this paper, however, are indirect since serum levels may not mirror a calcium depletion and since the patients were maintained on a fairly high calcium intake.
The possibility of the production of other deficiencies, such as magnesium, iron, thiamine, and riboflavin, has been suggested,'" 16 but we saw no evidence of this. However, until we are sure they do not occur, supplementary minerals and vitamins should be added during prolonged resin therapy.
Cation exchange resins have given the physician a new tool with which to remove from the body certain constituents which are undesirable. The observations reported in this paper indicate to the authors that such resins have a useful role in the therapy of chronic congestive heart failure but that they must be used with care and with due consideration of their limitations. Like any other manipulation of a biochemical and physiologic disturbance due to a disease state, resin therapy of the edematous cardiac requires careful thought concerning the individual patient. But used in this way, and not as an infallible panacea, it should develop into a dependable item of the physician's armamentarium. SUMMARY AND CONCLUSIONS Cation exchange resin, in the ammonium plus potassium cycle, was administered to 34 patients with edema due to chronic congestive heart failure. In 27 of these patients the treatment was sufficiently documented to permit assessment of its long-term effectiveness, the average length of therapy being 26.4 weeks and the maximum being 62 weeks. The results were as follows:
1. In terms of elimination of edema in previously refractory patients or of prevention of reaccumulation of edema during a decrease in mercurial diuretic and salt restriction therapy, the resin was effective in 23 of the 27 patients.
2. Gastrointestinal complications occurred in 20 of the 34 patients but required the discontinuance of the resin in only five patients.
3. No evidence of the following chemical complications were observed: sodium depletion, potassium depletion or intoxication, severe chloride acidosis or calcium depletion.
It is concluded that, with the careful selection of patients, cation exchange resin in this form is a useful and safe adjunct to the treatment of chronic congestive failure over prolonged periods of time.
